Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HSD17B8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FIBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APBB1IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERP29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AACS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLEC7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTP4A3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RYBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAI14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRCP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on